Replies to post #1191 on Enanta Pharmaceuticals Inc (ENTA)

[NY1972]

ENTA MC = 2X cash(2017)

Street expects ABBV 2nd gen to do worse than Harvoni in the most challenging population that is generating most of the scripts.

Harvoni + ribavirin for 12 weeks is now an FDA-approved regimen for GT1 treatment-experienced cirrhotic patients (as an alternative to Harvoni alone for 24 weeks).